CHRONIC LYMPHOID LEUKEMIA
Clinical trials for CHRONIC LYMPHOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC LYMPHOID LEUKEMIA trials appear
Sign up with your email to follow new studies for CHRONIC LYMPHOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for high-risk leukemia patients: early drug therapy shows promise
Disease control OngoingThis study tests whether giving the drug venetoclax early can help people with a slow-growing but high-risk form of chronic lymphocytic leukemia (CLL). About 82 participants with early-stage CLL who have certain risk factors will receive venetoclax. The main goal is to see how ma…
Matched conditions: CHRONIC LYMPHOID LEUKEMIA
Phase: PHASE2 • Sponsor: French Innovative Leukemia Organisation • Aim: Disease control
Last updated May 17, 2026 10:22 UTC
-
Major CLL trial tests three drug combos to find best control strategy
Disease control OngoingThis study compares three treatment approaches for people with previously untreated chronic lymphocytic leukemia (CLL): one drug taken continuously (ibrutinib), two drugs given for a fixed time (venetoclax plus obinutuzumab), and a combination of two drugs for a fixed time (ibrut…
Matched conditions: CHRONIC LYMPHOID LEUKEMIA
Phase: PHASE3 • Sponsor: German CLL Study Group • Aim: Disease control
Last updated May 04, 2026 16:32 UTC